Physician profile
Julia Ellen Cartledge
NPI 1023679073
$904.71
in general payments reported to CMS, 2019-2025
16 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.49 · 2023: $265 · 2024: $256 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $146.70 | 2023-2025 | Liletta |
| Coopersurgical, INC. | $100.14 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Baxter Healthcare | $93.18 | 2023 | Tisseel |
| Astellas Pharma US INC | $74.48 | 2025 | Veozah |
| Exeltis, USA INC. | $73.83 | 2023-2025 | Slynd |
| Organon LLC | $68.02 | 2024-2025 | Nexplanon |
| Biogen, INC. | $52.78 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $48.88 | 2025 | The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $42.74 | 2024 | Twirla |
| Conmed Corporation | $41.67 | 2023 | Airseal |
| Sumitomo Pharma America, INC. | $37.99 | 2023-2024 | Gemtesa |
| Mayne Pharma Commercial LLC | $37.47 | 2023-2025 | |
| Pfizer INC. | $25.86 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $24.87 | 2025 | Exparel |
| Hologic Sales and Service, LLC | $23.61 | 2025 | Myosure Tissue Removal Device |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Cartledge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.